TRT & men’s hormones telehealth
Who prescribes testosterone online, what it costs, and whether labs are included.
16 providers offer this. 4 include labs in the price. 0 accept insurance. Figures reflect what each provider publishes. * = provisional score.
Highest-scored providers
Data-driven clients who want extensive lab panels and coach-led, provider-supervised hormone optimization, and who will pay out of pocket without a clear upfront total.
Read the review → #2
Blokes 6.3 Men in one of the 34 eligible states who are willing to prepay several months of TRT to get a lower monthly price that includes medication and follow-up labs.
Read the review → #3
OneTwenty 9.2* People who mainly want frequent longevity lab testing and wearable data tracking, accept an upfront non-refundable annual fee, and treat prescriptions as an optional add-on.
Read the review →Ranked guides
All providers
| Clinic | Score | Consult | Labs | Prescriber | Insurance | From |
|---|---|---|---|---|---|---|
| Marek Health A telehealth clinic built around comprehensive bloodwork and physician-guided hormone optimisation, with TRT, peptide therapy and GLP-1 programmes. Known for an unusually deep lab panel. | 7.1 | Hybrid | Extra | MD/DO + NP/PA | Cash | $299 |
| A men’s telehealth clinic offering TRT, peptide therapy, GLP-1 weight loss and sexual health, with a sister brand for women. | 6.3 | Hybrid | Extra | MD/DO + NP/PA | Cash | $99/mo TRT on a 12-month plan |
| Bloodwork-led longevity and hormone optimisation telehealth, with physician-guided TRT, GLP-1 weight management and peptide therapy built on comprehensive lab panels. | 9.2* | — | Included | — | Cash | $499/yr membership |
| Male Excel A men’s telehealth provider offering TRT, ED treatment and weight loss with at-home testing. | 8.2* | — | Included | — | Cash | $99/mo membership |
| Rex MD Also offers A men’s telehealth provider offering ED medication, TRT and weight-loss treatment. | 7.6* | Async | n/a | — | Cash | $2/dose |
| One of the longest-running hormone telehealth clinics, offering TRT, HRT for women, peptide therapy and sexual health treatments with physician oversight. | 6.9* | Video | Extra | MD/DO + NP/PA | Cash | Under $175/mo average for TRT in year one |
| A large men’s hormone telehealth provider offering at-home lab testing, TRT and enclomiphene protocols, with a subscription model and physician video consults. | 6.9* | Video | Extra | MD/DO | Cash | $65 initial lab test |
| A testosterone-focused telehealth clinic with bundled lab work, physician prescribers and a single-tier subscription. | 6.8* | Hybrid | Included | — | Cash | $199 per 4 weeks |
| A men’s health telehealth brand offering TRT and enclomiphene protocols, a GLP-1 weight-loss programme, and hair and sexual health products. | 6.8* | Hybrid | Extra | MD/DO | — | $99.99/mo |
| A functional-medicine telehealth clinic offering bloodwork-driven hormone optimisation, TRT, peptide therapy and GLP-1 weight loss. | 6.8* | Video | Included | — | Cash | $125/mo Core care plan |
| TRT Nation A TRT telehealth clinic with a flat monthly subscription that includes medication and supplies. | 5.9* | — | Extra | — | — | $99.99/mo testosterone |
| A men’s preventive-health telehealth provider combining comprehensive bloodwork with TRT and sexual health treatment under a physician. | 5.4* | Video | Extra | MD/DO + NP/PA | Cash | $95/mo |
| A TRT telehealth clinic with physician consults and a subscription that includes medication. | 4.6* | Video | — | — | — | $99 lab order to start |
| A franchise network of men’s health clinics offering TRT, weight loss and ED treatment, with in-clinic visits and some telehealth follow-up. | Not scored | — | — | MD/DO + NP/PA | Cash | $199/mo |
| A telehealth provider known for lower-cost GLP-1 weight-loss programmes, also offering TRT, through a flat monthly subscription. | Not scored | Hybrid | — | — | Cash | $179/mo all-in |
| PeterMD A physician-only TRT telehealth clinic with a pay-as-you-go model rather than a subscription, and a weight-loss programme. | Not scored | — | Extra | — | — | $79/mo on an annual plan |
Head-to-head comparisons
Tools for this decision
What these clinics prescribe
Reference records for the compounds offered in this category. Mechanism, dosing ranges, evidence level and regulatory status for each.
- Gonadorelin — Synthetic gonadotropin-releasing hormone, increasingly used alongside TRT to maintain testicular function.
- hCG — A placental glycoprotein hormone that mimics LH directly at the testis, the long-standing standard for preserving fertility on TRT.
- PT-141 — A melanocortin-4 selective agonist approved for hypoactive sexual desire disorder, acting centrally rather than vascularly.
- Semaglutide — A long-acting GLP-1 receptor agonist and the compound that reset expectations for pharmacological weight loss.
- Sermorelin — The first 29 amino acids of endogenous growth-hormone-releasing hormone, and the shortest fragment that retains full biological activity.
- Tesamorelin — A stabilised GHRH analog and the only growth-hormone secretagogue with a current FDA approval for a body-composition indication.
- Tirzepatide — A dual GIP and GLP-1 receptor agonist that produced greater weight loss than semaglutide in head-to-head trial data.
References
Regulatory and primary sources
- American Urological Association clinical guidelines ↗ · includes the testosterone deficiency guideline
- Endocrine Society clinical practice guidelines ↗ · includes testosterone therapy in men
- DEA Diversion Control: testosterone is a Schedule III controlled substance ↗ · why TRT prescribing has extra rules
- HHS: Telehealth for patients ↗ · what to expect from a telehealth visit
- FDA: BeSafeRx, buying medicine online safely ↗ · how to check an online pharmacy
- NABP: Safe.Pharmacy verified websites ↗ · pharmacy accreditation lookup
- FSMB DocInfo: physician license lookup ↗ · check a prescriber is licensed
- FTC: Endorsements, influencers and reviews ↗ · disclosure rules for affiliate links
Published literature
- Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab 2018.PubMed 29562364 · doi:10.1210/jc.2018-00229
- Global Consensus Position Statement on the Use of Testosterone Therapy for Women.J Clin Endocrinol Metab 2019.PubMed 31498871 · doi:10.1210/jc.2019-01603
- The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation.Health Technol Assess 2024.PubMed 39248210 · doi:10.3310/JRYT3981
- Testosterone replacement therapy in men with type 2 diabetes mellitus and functional hypogonadism -an Integrated Diabetes and Endocrine Academy (IDEA) consensus guideline.Diabetes Metab Syndr 2021.PubMed 34245961 · doi:10.1016/j.dsx.2021.102191
- Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.Expert Opin Drug Saf 2024.PubMed 38553429 · doi:10.1080/14740338.2024.2337741
- Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.Thromb Res 2018.PubMed 30396049 · doi:10.1016/j.thromres.2018.10.023
- Guideline of guidelines: testosterone therapy for testosterone deficiency.BJU Int 2019.PubMed 31420972 · doi:10.1111/bju.14899
- Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis.BMJ Open 2017.PubMed 29150464 · doi:10.1136/bmjopen-2016-015284
Literature retrieved from PubMed on October 18, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.